ARTICLE SUMMARY:
Proposals issued in early August spell out a framework for the Brazilian government to create a price benchmarking database for implantables, starting with about a dozen cardiac devices. Industry groups remain optimistic the plan will address legal mandates while avoiding direct price controls.
Governments adopting concepts like reference pricing tend to make device manufacturers nervous. But a framework emerging in Brazil for a public price benchmarking database is so far being embraced by industry as a reasonable compromise to address country-specific issues without imposing price controls that could impede market access.
